Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients

F. Mercuriali, G. Barosi, G. Inghilleri, E. Biffi, A. Vinci, M. T. Colotti

Research output: Contribution to journalArticlepeer-review

Abstract

For patients who donate blood for autologous use and undergo major orthopedic surgery, low basal hematocrit (Hct) is the major cause of allogeneic blood exposure. To determine whether recombinant human erythropoietin (rHuEPO) could increase autologous blood procurement and reduce allogeneic blood exposure, a prospective randomized study was conducted in 50 women undergoing total hip replacement who had basal Hct

Original languageEnglish
Pages (from-to)55-60
Number of pages6
JournalTransfusion
Volume33
Issue number1
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Immunology
  • Hematology

Fingerprint Dive into the research topics of 'Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients'. Together they form a unique fingerprint.

Cite this